;46(2) 17] Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran. ;46(2)–17] Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran. ;46(2)–17]. Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration. Hiperkalsemia pada Keganasan: Karakteristik.

Author: Mezikinos Kazikinos
Country: Puerto Rico
Language: English (Spanish)
Genre: Technology
Published (Last): 8 October 2011
Pages: 93
PDF File Size: 15.95 Mb
ePub File Size: 8.37 Mb
ISBN: 912-3-39771-697-2
Downloads: 56040
Price: Free* [*Free Regsitration Required]
Uploader: Shaktirg

Gejala klinis yang ditemukan adalah gangguan kesadaran pada 4 subjek, dehidrasi pada 18 subjek, konstipasi pada 6 subjek, mual dan muntah pada 6 subjek. Click here to sign up. He is stabilized and treated in the intensive care unit.

Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran Terapi

Hasan Sadikin General Hospital Abstract Hypercalcemia is one of the most common paraneoplastic syndromes in hospitalized malignancy patients. Progression of HCM can be prevented with apropriate measures, including hydration, anticancer therapy, and treatment with bisphosphonates. Clinical Characteristics and Hiperkalsemiaa Outcome.

The dehydration leads to a reduction in the glomerular filtration rate that further reduces the ability of the kidney to excrete the excess serum calcium. McMahan J, Linneman T. This was a study using medical records of patients with malignancy hospitalized in the Departement of Internal Medicine, Dr.


Medical Necessity Criteria Subject: Among common paraneoplastic syndromes. CA Cancer J Clin. Advanced renal failure and other causes of More information.

WikiPage – eAnswers

Bisfosfonat, hiperkalsemia pada keganasan, rehidrasi Correspondence: It is particularly More information. Analisis statistik menggunakan Uji Wilcoxon. Hasan Sadikin Bandung periode Desember —Maret These results were consistent with the previous study that reported HCM hipperkalsemia present with wide range of symptoms but the development and severity of symptoms do not appear to be strictly correlated with serum calcium levels.

Tujuan penelitian ini untuk mengetahui karakteristik klinis dan respons terapi penderita dengan hiperkalsemia asalah keganasan.

The decision to treat hypercalcemia must take into consideration the potential benefits and burdens of therapy, the patient s place in the disease. Treatment of ;3 2: Hypercalcemia of malignancy and basic research on mechanisms responsible for osteolytic and osteblastic metastasis to bone.

If patients have urinary protein More information. Jpn J Clin Oncol. Today we will talk about the parathyroid gland. All hiperjalsemia ;43 9: The process of metabolism transforms lipophilic drugs into more polar, hydrophilic, readily Aealah information. The aim of this study was to determine the clinical characteristics and treatment outcome in hypercalcemia of malignancy.

The cytotoxic, non-hydrolyzable analogs of adenosine deinite treatment chemotherapy was given in triphosphate ATP that may inhibit ATP- 15 subjects.


Among 16 subjects without symptoms, we found mild, severe and life threatening HCM in 8, 4 and 4 subjects, respectively.

Nursing Pharmacology Principles 1. The study of how drugs enter the body, reach the site of action, and are removed from the body is called a.

First, therefore, parenteral volume expansion should be initiated, with the administration of normal saline. Download “Hiperkalsemia pada Keganasan: Stimulate an immune response against advanced prostate cancer Extend median survival beyond 2 years. The ion calcium level in subjects who did not received bisphosphonate was 6.

Disturbance of consiousness were found in 4, dehydration in 18, constipation in 6, and nausea and vomiting in 6 subjects. Bisphosphonate was given in 26 subjects.

Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran Terapi – PDF

Due to financial problem, all patients could not received zoledronic acid and received clodronic acid instead. Intracellular Fluid ICF 2. March 18, Xgeva Description Xgeva denosumab More information. MKB, Volume 46 No. What do kidneys normally do? Advanced renal failure and other causes of.

Normal level of calcium ion:

Last modified: January 1, 2020